Nifty Pharma index trades lower amid fragile markets; Alkem Lab, DR Reddys, Biocon drag

Sun Pharma, Lupin and Divis Lab also traded in the red. Auro Pharma was the lone gainer at Rs883.10 per piece, up 0.20%.

April 05, 2021 1:45 IST India Infoline News Service

Nifty Pharma was on the recovery path after joining the markets bears on Thursday. At around 1.45 pm, Nifty Pharma was trading near the day’s high of 12,383.55 at 12,306.15 down 70.95 points or 0.57%.

The second wave of Covid-19 in the country has become a dampener in markets sentiments as states grapple with partial lockdowns. The Index had made significant gains during the 2020 lockdown to curb Covid-19 infection and is likely to repeat the same performance if the intensity of Covid-19 infections keeps rising.

Alkem Lab, Biocon and DR Reddys dragged the sector most while Auro Pharma was marginally higher. 

Alkem Lab shed 2.2% at Rs2,711.05 per piece to emerge the biggest laggard. DR Reddys was 1% on the downside at Rs4,540.20 per piece. Biocon also dropped nearly 1% at Rs406.75 per piece. 

Torrent Pharma also lost 0.76%, Cipla and Cadila also were down 0.59% and 0.43% respectively.

Sun Pharma, Lupin and Divis Lab also traded in the red. 

Auro Pharma was the lone gainer at Rs883.10 per piece, up 0.20%. 

Related Story

Get Access to Stock Reports+ and Customised Investment Ideas